What is the recommended dose of Narcan (naloxone) for an opioid overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Naloxone (Narcan) Dosing for Opioid Overdose

For suspected opioid overdose, the recommended dose of OTC Narcan (naloxone) is 2 mg intranasally, which can be repeated in 3-5 minutes if no response occurs. 1

Dosing by Administration Route

  • Intranasal (OTC Narcan): 2 mg per dose, repeated in 3-5 minutes if necessary 1, 2
  • Intramuscular: 0.4-2 mg per dose, repeated every 2-3 minutes as needed 3, 4
  • Intravenous: 0.4-2 mg initially, repeated every 2-3 minutes as needed 3

Clinical Considerations

Patient Assessment

  • Prioritize airway management and breathing support before naloxone administration 5
  • Administer naloxone to patients with suspected opioid overdose who have a pulse but no normal breathing or only gasping 5
  • Continue standard BLS/ACLS care regardless of naloxone administration 5

Dosing Considerations

  • Higher doses may be required for synthetic opioid overdoses (e.g., fentanyl) 4
  • Use the lowest effective dose to minimize withdrawal symptoms while restoring respiration 1
  • Most reversals (97.6%) involve administration of ≤2 units of intranasal naloxone 2

Response Time

  • Most patients (73.5%) respond within 5 minutes of intranasal naloxone administration 2
  • Average response time to intranasal naloxone is approximately 3.4 minutes 6

Important Caveats

  • Naloxone's duration of action (1-2 hours) may be shorter than the respiratory depressant effects of many opioids, particularly long-acting formulations 5
  • Patients should be observed in a healthcare setting until risk of recurrent opioid toxicity is low and vital signs have normalized 5
  • Naloxone will not reverse respiratory depression due to non-opioid substances such as benzodiazepines 1
  • Naloxone may precipitate acute withdrawal syndrome in opioid-dependent patients 1

Special Populations

  • Pediatric patients: 0.1 mg/kg body weight IV initially; if inadequate response, may administer 0.1 mg/kg body weight 3
  • Patients with renal impairment: Standard dosing applies, but more frequent monitoring is recommended 5

Follow-up Care

  • If recurrent opioid toxicity develops, repeated small doses or an infusion of naloxone may be beneficial 5
  • For patients who respond to naloxone, continued observation is necessary due to the risk of recurrent respiratory depression 5

References

Guideline

Naloxone Dosing Considerations in Emergency Settings

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Intranasal administration of naloxone by paramedics.

Prehospital emergency care, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.